1-20 of 29
follow-up
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cure at what (systemic) financial cost? Integrating novel therapies into first-line Hodgkin lymphoma treatment

Scott F. Huntington
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 252–259.
https://doi.org/10.1182/hematology.2019000030
Published: 2019
Journal Articles

Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies

Richard J. Lin, Heidi D. Klepin
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 59–62.
https://doi.org/10.1182/hematology.2019000076
Published: 2019
Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.
https://doi.org/10.1182/asheducation-2018.1.213
Published: 2018
Journal Articles

TTP: long-term outcomes following recovery

James N. George
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 548–552.
https://doi.org/10.1182/asheducation-2018.1.548
Published: 2018
Journal Articles

Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution

Nancy L. Bartlett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 317–323.
https://doi.org/10.1182/asheducation-2017.1.317
Published: 2017
Journal Articles

Hereditary thrombocytopenias: a growing list of disorders

Patrizia Noris, Alessandro Pecci
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 385–399.
https://doi.org/10.1182/asheducation-2017.1.385
Published: 2017
Journal Articles

Treatment-free remission in CML: who, how, and why?

Francois-Xavier Mahon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 102–109.
https://doi.org/10.1182/asheducation.V2017.1.102.00014
Published: 2017
Journal Articles

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Marco Ruella, Pierre Soubeyran
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 432–436.
https://doi.org/10.1182/asheducation-2016.1.432
Published: 2016
Journal Articles

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Flora E. van Leeuwen, Andrea K. Ng
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 323–330.
https://doi.org/10.1182/asheducation-2016.1.323
Published: 2016
Journal Articles

Nontransplant therapy for bone marrow failure

Danielle M. Townsley, Thomas Winkler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 83–89.
https://doi.org/10.1182/asheducation-2016.1.83
Published: 2016
Journal Articles

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Tyler W. Buckner, Kenneth I. Ataga
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 432–437.
https://doi.org/10.1182/asheducation-2014.1.432
Published: 2014
Journal Articles

Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects

Andrea K. Ng
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 488–494.
https://doi.org/10.1182/asheducation-2014.1.488
Published: 2014
Journal Articles

Caring for the long-term survivor after allogeneic stem cell transplantation

Smita Bhatia
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 495–503.
https://doi.org/10.1182/asheducation-2014.1.495
Published: 2014
Journal Articles

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia

Richard F. Schlenk, Hartmut Döhner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 324–330.
https://doi.org/10.1182/asheducation-2013.1.324
Published: 2013
Journal Articles

Is there a role for warfarin anymore?

Alan Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 541–546.
https://doi.org/10.1182/asheducation.V2012.1.541.3798556
Published: 2012
Journal Articles

Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes

James N. George, Zayd L. Al-Nouri
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 604–609.
https://doi.org/10.1182/asheducation.V2012.1.604.3798564
Published: 2012
Journal Articles

How to use new biology to guide therapy in multiple myeloma

Gareth J. Morgan, Martin F. Kaiser
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 342–349.
https://doi.org/10.1182/asheducation.V2012.1.342.3798324
Published: 2012
Journal Articles

What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease?

Deepika S. Darbari, Julie A. Panepinto
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 290–291.
https://doi.org/10.1182/asheducation.V2012.1.290.3798273
Published: 2012
Journal Articles

Low blood counts: immune mediated, idiopathic, or myelodysplasia

Peter Valent
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 485–491.
https://doi.org/10.1182/asheducation.V2012.1.485.3798522
Published: 2012
Journal Articles

Fanconi Anemia

Jean Soulier
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 492–497.
https://doi.org/10.1182/asheducation-2011.1.492
Published: 2011